Dr. Diana Ursescu, hematologist – NORD Muntenia Hospital emphasizes the necessity for early prognosis and efficient communication between medical doctors and sufferers

On Might 28, throughout a webinar organized on the event of World Blood Most cancers Day, Dr. Diana Ursescu, hematologist at NORD Muntenia Hospital offered an in depth overview of the challenges and advances within the therapy of persistent and acute malignant hemopathies. She emphasised the significance of early prognosis, efficient collaboration between household medical doctors and specialists, but additionally the important position of household help and sufferers’ will to combat.

Dr. Diana Ursescu, A hematologist on the NORD Muntenia Hospital, in a Caspa.ro dialogue, shared his experiences from apply, stressing that though the therapies comply with strict protocols, the response of the sufferers can range vastly.

“For over a dozen years, I have been attempting to grasp and deal with blood cancers, and simply once I suppose I’ve figured it out and succeeded, a shock occurs up It occurs that I’ve two sufferers with the identical age, the identical prognosis, the identical intercourse, and we start to deal with each the identical, in keeping with the protocols. However to my shock, even when they’re the identical illnesses, the identical therapy, certainly one of them responds and goes into remission, and the opposite doesn’t have the identical therapeutic response.”

The webinar was organized by A group of affected person associations – Caspa.ro with help North Muntenia Hospitalto mark World Blood Most cancers Day, celebrated yearly on Might 28, as a wake-up name for consciousness of the significance of any such most cancers. Her image, the signal & coloured crimson, it reveals closeness to folks affected by blood cancers.

In his intervention, Dr. Ursescu highlighted the important position of household help and the sufferers’ want to combat: “At all times half of the therapy, and that is true for all illnesses, not just for blood illnesses, the affected person’s want to get well and reside, and the household help that offers him power.”

One other vital side coated within the webinar was the good progress within the therapy of malignant hemopathies due to superior applied sciences and trendy therapies similar to stem cell transplantation and focused molecules. Dr. Diana Ursescu famous that “the medical progress in therapy today, if we solely speak about stem cell transplantation and focused molecular therapy, has made the prognosis a lot better for blood cancers.”

Early prognosis is crucial

The hematologist additionally drew consideration to the significance of normal medical exams for the early prognosis of those illnesses, stressing that numerous forms of persistent malignant hemopathies, together with persistent myeloid leukemia, polycythemia and important thrombocythemia might be detected by way of easy blood depend: “Most cancers of blood can solely be prevented by early prognosis, however early prognosis at an early stage vastly will increase the success fee. I counsel each sufferers and relations to watch out. “

And the principle and easiest transfer we should always make is the banal blood depend.

“My recommendation to everyone seems to be, first, let’s do our evaluation. Analyzes imply a traditional blood depend, a few times a 12 months, by way of the household physician or the specialist, as a result of we are able to discover adjustments within the blood that assist us discover an issue a lot quicker. The blood depend shouldn’t be just for the hematologist, it’s the alphabet of medication.

Customized therapy is now a actuality

Concerning acute malignant hemopathies, Dr. Ursescu highlighted the principle issues encountered within the therapy of acute leukemias and myelomas. “Acute leukemia has a poor prognosis, even with new focused therapies and stem cell transplantation, an excellent prognosis shouldn’t be assured,” mentioned Dr. Ursescu. “Myelomas are additionally blood illnesses with a poor two-year prognosis, however due to medical advances, we are able to attain a five-year prognosis with out energetic illness.”

One other vital side that was thought-about was the necessity to personalize the therapy in keeping with the affected person’s genetic profile and preferences. “There may be a person therapy for every particular person affected person, for his genetic profile, for the affected person’s comorbidities and for his needs,” defined Dr. Ursescu. “The affected person’s want can also be vital, to do long-term therapy or short-term therapy, relying on every particular person’s preferences and circumstances.”

She additionally emphasised the significance of efficient communication between the physician and the affected person, as it’s important for the success of the therapy: “Communication between the physician and the affected person is a two-way road: I’ve to hearken to the affected person and the affected person. should hearken to me. The vital factor is to respect and belief one another.”

In conclusion, Dr. Diana Ursescu appealed to household medical doctors to play an energetic position within the early prognosis of malignant hemopathies and to collaborate successfully with specialists to maximise the probabilities of therapy and remission. higher for sufferers.

About Caspa.ro

Developed by Folks and Firms since 2015, with the purpose of supporting and rising the visibility of the affected person group in Romania, CASPA group has introduced collectively its members in additional than 40 totally different actions, and since 2017 it additionally advantages from its personal digital platform, www.caspa.ro.

Keep linked with group actions by subscribing to the weekly e-newsletter right here: https://www.caspa.ro/e-newsletter/ or by following our web page Fb or linked.